Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prilosec OTC Covered By Michigan Blues In Bid To Convert Nexium Patients

This article was originally published in The Tan Sheet

Executive Summary

Blue Cross Blue Shield of Michigan is covering Prilosec OTC for heartburn and acid reflux disease and is seeking to convert Nexium users, reflecting increasing attention from insurers to over-the-counter drugs as vehicles for savings

You may also be interested in...



Perrigo Pursues OTC Reimbursement Opportunity In Emerging "ORx" Space

Perrigo has entered a nascent growth channel by pursuing reimbursement for OTC drugs prescribed by doctors and dispensed by pharmacists

Perrigo Pursues OTC Reimbursement Opportunity In Emerging "ORx" Space

Perrigo has entered a nascent growth channel by pursuing reimbursement for OTC drugs prescribed by doctors and dispensed by pharmacists

Perrigo Pursues OTC Reimbursement Opportunity In Emerging "ORx" Space

Perrigo has entered a nascent growth channel by pursuing reimbursement for OTC drugs prescribed by doctors and dispensed by pharmacists

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS100892

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel